CYNTHIA MARTINEZ: Open Payments
NPI 1538846159 · AVONDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 28 payments from 11 companies in 2025. Trend: 2023 $27 · 2024 $439 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | 5 | $130 |
| PFIZER INC. | 5 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| Ferring Pharmaceuticals Inc. | 4 | $79 |
| Merck Sharp & Dohme LLC | 2 | $61 |
| Janssen Biotech, Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| UROGEN PHARMA, INC. | 1 | $22 |
| COLOPLAST CORP | 1 | $16 |
Products named: PYLARIFY, XTANDI, PLUVICTO, ADSTILADRIN, ERLEADA, BOTOX, LYNPARZA, GEMTESA.
Industry payments across AZ — which companies pay providers there.
